[1] |
WU Yujie, ZHAO Chengcheng, XI Qing.
Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
|
[2] |
ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng.
Model informed precision dosing of warfarin: China expert consensus report (2022 version)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.
|
[3] |
LIU Wei, XUE Junsheng, YU Zhiheng, WANG Ziyu, CHEN Rong, ZHOU Tianyan.
Interpretation of pharmacokinetic-based criteria for supporting alternative dosing regimens of programmed cell death receptor-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) blocking antibodies for treatment of patients with cancer guidance for industry
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 86-94.
|
[4] |
ZHANG Ningyuan, ZHENG Xijun, XU Ling, LIU Hongxia, ZHENG Qingshan.
Disease progression model for Alzheimer's disease and its research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 687-694.
|
[5] |
JIAO Zheng, LI Xingang, SHANG Dewei, DONG Jing, ZUO Xiaocong, CHEN Bing, LIU Jianmin, PAN Yan, ZHOU Tianyan, ZHANG Jing, LIU Dongyang, LI Lujin, FANG Yi, MA Guangli, DING Junjie, ZHAO Wei, CHEN Rui, XIANG Xiaoqiang, WANG Yuzhu, GAO Jianjun, XIE Haitang, HU Pei, ZHENG Qingshan.
Model informed precision dosing: China expert consensus report
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1215-1228.
|
[6] |
LI Jian, YANG Jinbo, WANG Yuzhu.
Discussion on the format and content of new drug population pharmacokinetic study report
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 546-549.
|
[7] |
XU Gaoqi, ZHANG Yiwen, ZHENG Xiaowei, LIU Yujia, LI Li, HUANG Ping.
Missed and remedial dosage regimens of erlotinib by Monte Carlo simulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 540-545.
|
[8] |
ZHANG Huimin, LIU Aiming, ZHU Wenfeng, YU Lingzhi, CHEN Fangliang.
Scientific decision process and regulation requirements based on the current guidelines of data extrapolation from adult to pediatric population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 49-56.
|
[9] |
YIN Fang, WANG Yuzhu, ZHENG Qingshan.
Dose selection of indacaterol for marketing approval: a FDA story in pharmacometrics review
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1031-1039.
|
[10] |
JI Shuangmin, ZHU Xiao, GAO Liucun, YANG Huan, GAO Chenyan.
Research advances on target-mediated drug disposition(TMDD) models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 481-487.
|
[11] |
SHANG Feng, YU Chengkai, YANG Peng.
Bridging method of adjusted significance levels α' in the target region concerning superiority design for normal data distribution in MRCT
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 59-64.
|
[12] |
WU Yonglei, WANG Dan, ZHANG Suiyang, WANG Ying, SUN Qin.
Pharmacokinetics and pharmacodynamics of meropene administered by traditional prolonged infusion or optimized prolonged infusion in different tissues of septic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 767-774.
|
[13] |
LU Meng-Jie, ZHONG Wei-Hua, LIU Yu-Xiu, LI Yong-Chang, MIAO Hua-Zhang.
Sample Size Calculations for Equivalence Clinical Trials by Decomposing β
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(6): 647-652.
|
[14] |
YE Long-qiang, SHI Lin-hui, QIU Xiao-hui, JIN Yu-hong, CAI Ting.
Pharmacodynamics of prolonged dosing regimens of four β-lactam antibiotics against severe infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(1): 51-55.
|
[15] |
YU Li-li, BU Xiao-dong, GU Xin, DU Qian, XIA Jie-lai.
Explore on the effects of General Friedman's Urn Model on power in clinical trial through simulation experiments
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 286-289.
|